Walleye Capital’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-264,800
Closed -$741K 4805
2025
Q4
$741K Buy
264,800
+219,600
+486% +$785K ﹤0.01% 2662
2025
Q3
$217K Sell
45,200
-15,700
-26% -$99.9K ﹤0.01% 3265
2025
Q2
$554K Buy
60,900
+59,200
+3,482% +$436K ﹤0.01% 2557
2025
Q1
$15.4K Buy
+1,700
New +$17.9K ﹤0.01% 4039
2024
Q3
Sell
-11,400
Closed -$154K 5718
2024
Q2
$154K Buy
+11,400
New +$233K ﹤0.01% 4471
2023
Q3
Sell
-200
Closed -$3.81K 5193
2023
Q2
$3.81K Hold
200
﹤0.01% 4073
2023
Q1
$2.91K Buy
+200
New +$3.58K ﹤0.01% 3727
2022
Q4
Sell
-4,900
Closed -$118K 3506
2022
Q3
$118K Buy
+4,900
New +$151K ﹤0.01% 2352

Other funds holding ACH

Walleye Capital's ACH Position: Q1 2026 in Review

Walleye Capital reduced its Accendra Health (ACH) stake by 98% in Q1 2026, selling an estimated $1.37M and leaving 12,000 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4026.

Walleye Capital first reported a position in ACH in Q2 2019 and has held it in 12 quarters since. The position peaked at $2.4M in Q1 2025. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

  • Walleye Capital held 12,000 shares of Accendra Health worth $27.4K as of Q1 2026.
  • Walleye Capital sold 596,231 Accendra Health shares in Q1 2026, an estimated $1.37M.
  • Accendra Health made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4026 holding.
  • Walleye Capital first reported a position in Accendra Health in Q2 2019 and has held it in 12 quarters since.
  • Walleye Capital's Accendra Health position peaked at $2.4M in Q1 2025.
  • 142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.